Cargando…
No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
There is an urgent need for biomarkers to enable early diagnosis of Alzheimer's disease (AD). It has recently been shown that a variant within the clusterin gene is associated with increased risk of AD and plasma levels of clusterin have been found to be associated with the risk of AD. We, ther...
Autores principales: | Silajdžić, Edina, Minthon, Lennart, Björkqvist, Maria, Hansson, Oskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509147/ https://www.ncbi.nlm.nih.gov/pubmed/23209684 http://dx.doi.org/10.1371/journal.pone.0050237 |
Ejemplares similares
-
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
por: Silajdžić, Edina, et al.
Publicado: (2015) -
Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
por: Björkqvist, Maria, et al.
Publicado: (2012) -
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
por: Stomrud, Erik, et al.
Publicado: (2010) -
A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
por: Silajdžić, Edina, et al.
Publicado: (2018) -
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study
por: Hertze, Joakim, et al.
Publicado: (2014)